Evaluation Of Caudal Epidural Anatomy By Ultrasonography İn Pediatric Patients

NCT ID: NCT03825172

Last Updated: 2022-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

348 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-28

Study Completion Date

2020-01-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Detailed study of ultrasonographic caudal epidural anatomy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Caudal epidural block is one of the most common methods to provide analgesia for an infraumbilical surgery in children. Although it can be carried out safely and easily, many complications have been described so far, because of inaccurate needle injections. To perform a successful block, a good caudal epidural anatomic assessment is essential. Ultrasonography is an important tool to perform pediatric regional blocks, including caudal blocks. We believe that caudal epidural ultrasound evaluation can be an important option to decrease complications and to achieve a successful attempt; due to that we will try to describe caudal epidural ultrasound imaging and changes from one month to 84 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia, Caudal Anatomy Ultrasonography Pediatrics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

Caudal Epidural Ultrasonography will be performed in patients aged between 1-24 months

Caudal Epidural Ultrasonography

Intervention Type DIAGNOSTIC_TEST

Ultrasonographic Measurement

Group II

Caudal Epidural Ultrasonography will be performed in patients aged between 25-48 months

Caudal Epidural Ultrasonography

Intervention Type DIAGNOSTIC_TEST

Ultrasonographic Measurement

Group III

Caudal Epidural Ultrasonography will be performed in patients aged between 49-84 months

Caudal Epidural Ultrasonography

Intervention Type DIAGNOSTIC_TEST

Ultrasonographic Measurement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Caudal Epidural Ultrasonography

Ultrasonographic Measurement

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric patients who applied for any pediatric surgery from 20 january to 20 july

Exclusion Criteria

* Premature patients
* Patients who have any sendromic diagnosis
* Patients who have any musculoskeletal abnormalities
* Patients who have any spinal abnormalities
Minimum Eligible Age

1 Month

Maximum Eligible Age

84 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pinar Kendigelen

UNKNOWN

Sponsor Role collaborator

Ayse Cigdem Tutuncu

OTHER

Sponsor Role collaborator

Kaya, Guner, M.D.

INDIV

Sponsor Role collaborator

Istanbul University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Celal Kaya

resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Celal Kaya, MD

Role: PRINCIPAL_INVESTIGATOR

Istanbul University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cerrahpasa Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

72109855-604.01.01-103424

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.